MedTrace Logo

Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy

NCT03096496 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 161

Last updated 2021-02-08

No results posted yet for this study

Summary

This is a prospective and international observational study run by the GIMEMA. All data will be centrally collected and analyzed at the GIMEMA Data Center in Rome (Italy). Patients reported outcomes will be collected using internationally validated questionnaires.

Conditions

  • Acute Promyelocytic Leukemia

Interventions

OTHER

QoL questionnaires

Quality of life questionnaires

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Fabio Efficace · GIMEMA Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-27
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03096496 on ClinicalTrials.gov